Evaluation of Healthcare Utilisation and Expenditures in Persons with Type 2 Diabetes Undergoing Bariatric-Metabolic Surgery.
Valerie M MonpellierRose J GeurtenIgnace M C JanssenDirk RuwaardJeroen N StruijsPeter R van DijkHenk J G BiloArianne Mathilda Josephus ElissenPublished in: Obesity surgery (2024)
BMS in people with T2DM stabilises healthcare expenditures and decreases medication use and care use for microvascular complications. In contrast, healthcare use and expenditures in T2DM patients who do not undergo surgery gradually increase over time. Due to the progressive nature of T2DM, it is expected that these differences will become larger in the long-term.
Keyphrases
- healthcare
- minimally invasive
- coronary artery bypass
- health insurance
- magnetic resonance
- multiple sclerosis
- weight loss
- surgical site infection
- magnetic resonance imaging
- risk factors
- quality improvement
- health information
- type diabetes
- computed tomography
- acute coronary syndrome
- metabolic syndrome
- bariatric surgery
- percutaneous coronary intervention
- skeletal muscle
- insulin resistance
- chronic pain
- pain management